{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:05:33Z","timestamp":1762099533939},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1006\/mpat.1999.0302","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:37:46Z","timestamp":1034001466000},"page":"243-252","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever"],"prefix":"10.1006","volume":"27","author":[{"given":"Masayuki","family":"Shiseki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kachiko","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiko","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Totsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ooe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikata","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mpat.1999.0302_RF1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198707163170305","article-title":"Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes","volume":"317","author":"Cone","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1006\/mpat.1999.0302_RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1006\/mpat.1999.0302_RF3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1006\/mpat.1999.0302_RF4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1993.03500030082037","article-title":"The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococci toxic shock-like syndrome","volume":"269","author":"Hoge","year":"1993","journal-title":"JAMA"},{"key":"10.1006\/mpat.1999.0302_RF5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid0103.950301","article-title":"Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment","volume":"1","author":"Stevens","year":"1995","journal-title":"Emerg Infect Dis"},{"key":"10.1006\/mpat.1999.0302_RF6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.11150\/kansenshogakuzasshi1970.67.236","article-title":"Case report of toxic shock-like syndrome due to group A streptococcal infection","volume":"67","author":"Shimizu","year":"1993","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1006\/mpat.1999.0302_RF7","first-page":"476","article-title":"Clinical and pathological study of cases with severe type GAS infection","volume":"16","author":"Shimizu","year":"1994","journal-title":"Asahi Cho Ihou"},{"key":"10.1006\/mpat.1999.0302_RF8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0046-8177(97)90043-5","article-title":"A new type of fulminant group A streptococcal infection in obstetrics patients: Report of two cases","volume":"28","author":"Ooe","year":"1997","journal-title":"Humn Pathol"},{"key":"10.1006\/mpat.1999.0302_RF9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome","volume":"269","author":"The Working Group on Severe Streptococcal Infections","year":"1993","journal-title":"JAMA"},{"key":"10.1006\/mpat.1999.0302_RF10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","article-title":"Toxic-shock syndrome associated with phage-group-I staphylococci","volume":"2","author":"Todd","year":"1978","journal-title":"Lancet"},{"key":"10.1006\/mpat.1999.0302_RF11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198012183032501","article-title":"Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention","volume":"303","author":"Davis","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1006\/mpat.1999.0302_RF12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.7326\/0003-4819-96-6-843","article-title":"Clinical and laboratory manifestations of toxic shock syndrome","volume":"96","author":"Tofte","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1006\/mpat.1999.0302_RF13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.131.4.745","article-title":"The toxicity of streptolysin O for beating mammalian heart cells in tissue culture","volume":"131","author":"Thompson","year":"1970","journal-title":"J Exp Med"},{"key":"10.1006\/mpat.1999.0302_RF14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1084\/jem.118.2.223","article-title":"Motion picture study of the toxic action of streptolysins on leukocytes","volume":"118","author":"Hirsch","year":"1963","journal-title":"J Exp Med"},{"key":"10.1006\/mpat.1999.0302_RF15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0163-7258(80)90045-5","article-title":"Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin)","volume":"11","author":"Alouf","year":"1980","journal-title":"Pharmacol Ther"},{"key":"10.1006\/mpat.1999.0302_RF16","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.145.10.3170","article-title":"Activation of murine T cells by streptococcal pyrogenic exotoxin A. Requirement for MHC class II molecules on accessory cells and identification of V\u03b2 elements in T cell receptor of toxin-reactive T cells","volume":"145","author":"Imanishi","year":"1990","journal-title":"J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF17","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.4049\/jimmunol.146.11.3747","article-title":"Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B","volume":"146","author":"Abe","year":"1991","journal-title":"J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF18","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1128\/IAI.60.12.5025-5029.1992","article-title":"Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B","volume":"60","author":"Imanishi","year":"1992","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.1999.0302_RF19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(08)60534-9","article-title":"Superantigens and their potential role in human disease","volume":"54","author":"Kotzin","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1006\/mpat.1999.0302_RF20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1348-0421.1994.tb01772.x","article-title":"Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases","volume":"38","author":"Uchiyama","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1006\/mpat.1999.0302_RF21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/IAI.64.3.870-877.1996","article-title":"Streptococcal cysteine protease augments lung injury induced by products of group A streptococci","volume":"64","author":"Shanley","year":"1996","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.1999.0302_RF22","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1074\/jbc.270.17.9862","article-title":"Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins","volume":"270","author":"Berge","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1006\/mpat.1999.0302_RF23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.184.2.665","article-title":"Streptococcal cystein proteinase releases kinins: a novel virulence mechanism","volume":"184","author":"Herwald","year":"1996","journal-title":"J Exp Med"},{"key":"10.1006\/mpat.1999.0302_RF24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1542\/peds.96.3.428","article-title":"Group A \u03b2-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella","volume":"96","author":"Doctor","year":"1995","journal-title":"Pediatrics"},{"key":"10.1006\/mpat.1999.0302_RF25","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/clinids\/21.5.1220","article-title":"Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypable clone","volume":"21","author":"Carapetis","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1006\/mpat.1999.0302_RF26","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1128\/JCM.27.8.1890-1892.1989","article-title":"Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness","volume":"27","author":"Lee","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1006\/mpat.1999.0302_RF27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2249.1994.tb06620.x","article-title":"Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo","volume":"98","author":"Michie","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1006\/mpat.1999.0302_RF28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/171.1.74","article-title":"Selective depletion of V\u03b2-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome","volume":"171","author":"Watanabe-Ohnishi","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.1999.0302_RF29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.186.3.375","article-title":"The superantigen streptococcal pyrogenic exotoxin C (Spe-C) exhibits a novel mode of action","volume":"186","author":"Li","year":"1997","journal-title":"J Exp Med"},{"key":"10.1006\/mpat.1999.0302_RF30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1172\/JCI116641","article-title":"A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C","volume":"92","author":"Mollick","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1006\/mpat.1999.0302_RF31","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/IAI.62.12.5227-5233.1994","article-title":"Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)","volume":"62","author":"Norrby-Teglund","year":"1994","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.1999.0302_RF32","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1128\/IAI.65.9.3828-3833.1997","article-title":"Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcal pyogenes","volume":"65","author":"Kamezawa","year":"1997","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.1999.0302_RF33","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.4049\/jimmunol.152.4.2066","article-title":"Characterization of unique human TCR-V\u03b2 specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein","volume":"152","author":"Watanabe-Ohnishi","year":"1994","journal-title":"J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/jcp.46.7.617","article-title":"Rapidly fatal necrotising fasciitis caused by Streptotoccus pyogenes","volume":"46","author":"Donaldson","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1006\/mpat.1999.0302_RF35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/clinids\/21.6.1469","article-title":"Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review","volume":"21","author":"Lamothe","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1006\/mpat.1999.0302_RF36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of group A streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF37","first-page":"638","article-title":"Study of the biological activities of toxic shock syndrome toxin-1. II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin","volume":"68","author":"Uchiyama","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1006\/mpat.1999.0302_RF38","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/eji.1830191007","article-title":"Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules","volume":"19","author":"Uchiyama","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF39","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0140-6736(97)11125-4","article-title":"Exanthematous disease induced by toxic shock syndrome toxin-1 in the early neonatal period","volume":"351","author":"Takahashi","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/mpat.1999.0302_RF40","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.4049\/jimmunol.151.8.4407","article-title":"Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudo\u00cdtuberculosis isolated from patients manifesting acute and systremicc symptoms","volume":"151","author":"Uchiyama","year":"1993","journal-title":"J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF41","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.4049\/jimmunol.154.10.5228","article-title":"DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis -derived mitogen (YPM), and characterization of the gene product, clond YPM","volume":"154","author":"Miyoshi-Akiyama","year":"1995","journal-title":"J Immunol"},{"key":"10.1006\/mpat.1999.0302_RF42","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1128\/IAI.56.9.2474-2478.1988","article-title":"Heterogeneity of hemolytic efficiency and isoelectoric point of streptolysin O","volume":"56","author":"Suzuki","year":"1988","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.1999.0302_RF43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/infdis\/172.2.558","article-title":"The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease","volume":"172","author":"Terai","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.1999.0302_RF44","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1139\/m96-142","article-title":"Expression of T-cell receptor V beta 2 and type 1 helper T-cell-related cytokine mRNA in streptococcal pyrogenic exotoxin-C-activated human peripheral blood mononuclear cells","volume":"42","author":"Ohara-Nemoto","year":"1996","journal-title":"Can J Microbiol"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401099903029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401099903029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T12:23:19Z","timestamp":1680610999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401099903029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["S0882401099903029"],"URL":"https:\/\/doi.org\/10.1006\/mpat.1999.0302","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}